Profiles: Page 2

The latest opinion pieces by industry thought leaders


  • A portrait of Sarah Hersey framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Sarah Hersey

    Innovators: Sarah Hersey

    At Bristol Myers Squibb, Sarah Hersey challenges the norm — and herself — to continually bring the best solutions to patients as vice president of translational sciences and diagnostics.

    Alexandra Pecci • Sept. 6, 2022
  • A portrait of Samantha Singer framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Samantha Singer

    Disrupters: Samantha Singer

    Abata’s CEO is stepping into the ring to fight for patients with progressive MS and other autoimmune disorders.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Sally Allain framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Sally Allain

    Disrupters: Sally Allain

    The newest location for Johnson & Johnson Innovation’s incubator JLABS is in Washington, D.C., and the head of the cutting-edge space is bringing a diverse set of disruptive companies together.

    Michael Gibney • Sept. 6, 2022
  • A portrait of Rosalind Brewer framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Rosalind Brewer

    Disrupters: Rosalind Brewer

    The CEO of Walgreens Boots Alliance is transforming the pharmacy powerhouse into a major new player in the healthcare space.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Rich Christie framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Rich Christie

    Tech Wizards: Dr. Rich Christie

    Driven by an enthusiasm for invention and a connection between scientific expertise and patient outcomes, the AiCure chief medical officer looks to nurture AI-powered technology.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Renata Campos framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Renata Campos

    DE&I Champions: Renata Campos

    Takeda's Growth and Emerging Markets Business Unit president is driving growth by doing what’s right for patients and her teams.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Raymond Stevens framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Raymond Stevens

    Legacy Leaders: Raymond Stevens

    The longtime pioneer in new drug discovery methods and founder of Structure Therapeutics has leveraged innovative science for commercial success.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Rahul Ballal framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Rahul Ballal

    Legacy Leaders: Rahul Ballal

    Imara’s CEO walks the walk when it comes to being a patient-first company by empowering his teams to lead important initiatives with far-ranging impact.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Rafael Amado framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Rafael Amado

    Innovators: Dr. Rafael Amado

    Quiet, supportive and collaborative leadership have made the R&D leader a standout innovator for Allogene Therapeutics.

    Alexandra Pecci • Sept. 6, 2022
  • A portrait of Rachel Lenington framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Rachel Lenington

    Legacy Leaders: Rachel Lenington

    Athira Pharma’s COO is striving to transform the landscape for patients with Alzheimer’s and other neurodegenerative diseases.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Penelope Manasco framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Penelope Manasco

    Entrepreneurs: Dr. Penelope Manasco

    How the NIH-trained scientist and CEO of MANA RBM is charting a new way forward in conducting clinical trials.

    Alexandra Pecci • Sept. 6, 2022
  • A portrait of Otis Johnson framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Otis Johnson

    DE&I Champions: Otis Johnson

    Clario’s chief diversity, inclusion and sustainability officer is looking to improve clinical trial recruitment with a bottom-up approach that first focuses on internal hiring practices. 

    Karissa Waddick • Sept. 6, 2022
  • A portrait of Nina Wachsman framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Nina Wachsman

    Entrepreneurs: Nina Wachsman

    The CEO and co-founder of Know Rare is on a mission to connect rare disease patients with researchers and clinical trials.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Nello Mainolfi framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Nello Mainolfi

    Entrepreneurs: Nello Mainolfi

    Kymera Therapeutics’ CEO is chasing untreated disease targets by advancing a game-changing technology.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Nekzad Shroff framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Nekzad Shroff

    Tech Wizards: Nekzad Shroff

    Considered one of the industry’s ‘most powerful minds,’ the VP of product management at Saama is developing digital solutions with impact.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Nancy Lurker framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Nancy Lurker

    Legacy Leaders: Nancy Lurker

    The CEO of EyePoint Pharmaceuticals is positioning the company to fundamentally reshape how retinal diseases are treated.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Mike Gladstone framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Mike Gladstone

    Legacy Leaders: Mike Gladstone

    The global president of Pfizer's Inflammation and Immunology unit is unlocking his team’s potential to meet big goals against a promising pipeline.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Maureen Hennessey framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Maureen Hennessey

    DE&I Champions: Maureen Hennessey

    The senior vice president, director of value transformation at PRECISIONvalue is moving the needle on patient nonadherence challenges.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Matt Walz framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Matt Walz

    Tech Wizards: Matt Walz

    The innovative CEO is driving global clinical trial enrollment with a novel approach for the industry.   

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Matt Clark framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Matt Clark

    Tech Wizards: Matt Clark

    X-Chem’s CEO has pioneered DNA-encoded libraries to revolutionize small molecule discovery.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Mary-Ann Etiebet framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Mary-Ann Etiebet

    DE&I Champions: Dr. Mary-Ann Etiebet

    Merck’s associate vice president of health equity is making DE&I a part of the pharma giant's day-to-day strategy.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Mark Sullivan framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Mark Sullivan

    DE&I Champions: Mark Sullivan

    Medicines Development for Global Health’s founder is committed to eliminating neglected tropical diseases around the world.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Mark Goldberg framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Mark Goldberg

    Legacy Leaders: Dr. Mark Goldberg

    The savvy clinical trials pro has built a global CRO by targeting the needs of the industry’s bustling biotech sector.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Lori Abrams framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Lori Abrams

    DE&I Champions: Lori Abrams

    The VP of patient advocacy and clinical research diversity at WCG is shaking up the trial space by shining a light on underserved populations.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Lisa Walters-Hoffert framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Lisa Walters-Hoffert

    Entrepreneurs: Lisa Walters-Hoffert

    Daré Bioscience’s CFO and co-founder is determined to rapidly advance innovations in women’s health.

    PharmaVoice staff • Sept. 6, 2022